ProCE Banner Activity

The Itch–Scratch Cycle in Atopic Dermatitis: Disease Burden and Management Strategies

Clinical Thought

Learn key takeaways regarding the disease burden of atopic dermatitis from the patient and family/caregiver perspectives as well as strategies for treatment selection that take into consideration symptom relief and disease control needs.

Released: April 11, 2025

Expiration: April 10, 2026

Share

Provided by

Provided by Partners for Advancing Clinical Education (PACE), in partnership with the Coalition of Skin Diseases (CSD).

ProCE Banner

Supporters

Supported by educational grants from Sanofi and Regeneron Pharmaceuticals, and Incyte.

Incyte

Regeneron Pharmaceuticals

Sanofi

Partners

Coalition of Skin Diseases (CSD)

ProCE Banner

Disclosure

Primary Author

Heather Woolery-Lloyd, MD: consultant/advisor/speaker: AbbVie, Arcutis, Beiersdorf, Galderma, Incyte, Kenvue, Loreal, Ortho Dermatologics, Pfizer, Proctor and Gamble, SC Johnson, Unilever; researcher: AbbVie, Allergan, Arcutis, Avita, Eirion, Galderma, Pfizer, Teoxane Laboratories.